Michael Diem
Equibles does not estimate personal net worth.
Get an email with a short summary when Century Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get IPSC alertsAbout Michael Diem
Michael Diem is recorded as CFO at Century Therapeutics, Inc. (IPSC) since April 11, 2023. Century Therapeutics, Inc. reported in an 8-K filed April 17, 2023 that Michael Diem was appointed Chief Financial Officer, effective April 11, 2023. Century Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Century Therapeutics, Inc. includes Brent Pfeiffenberger (CEO and Chairman), Gregory Russotti, Ph.D. (CEO), Brent Pfeiffenberger, Pharm.D. (Chairman) and 7 others.
“On April 11, 2023, the Board promoted Michael Diem to Chief Financial Officer.”
Affiliation history
-
Current
2023-04-11–present
-
Century Therapeutics, Inc. (IPSC)
Proxy statement
Start not stated–2022-04-21
Last confirmed by a filing; no departure on record
-
Start not stated–2024-02-02
Company network
Leadership on record at Century Therapeutics, Inc.
- Brent Pfeiffenberger CEO, Chairman
- Gregory Russotti, Ph.D. CEO
- Brent Pfeiffenberger, Pharm.D. Chairman
- Douglas Carr CFO
- Morgan Conn, Ph.D. CFO
- Gregory Russotti CTO
- Alessandro Riva Board Member
- Dr. Han Lee Board Member
- Dr. Martin Murphy Board Member
- Han Lee Board Member